Syngene Financial Statements

Syngene (SYNGENE) reported revenue of ₹37.39B in FY2026 with net income of ₹3.17B. Total assets stood at ₹70.55B. Net worth was ₹48.39B (₹4,839 Cr) and free cash flow was ₹5.71B.

Syngene Income Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Revenue		36.42B	37.39B
Cost of Rev. Cost of Revenue		-9.43B	-9.19B
Gross Profit		27.00B	28.20B
SGA Sales, General & Admin		-16.58B	-19.02B
Op. Income Operating Income		6.09B	4.66B
PBT Profit Before Tax		6.60B	4.11B
Net Income		4.96B	3.17B
Dil. Shares Diluted Shares		402.32M	402.41M
Diluted EPS		12.34	7.87

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Syngene's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Syngene Balance Sheet

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Curr. assets Total current assets		22.87B	21.43B
Non-curr. assets Total non-current assets		45.09B	49.12B
Total assets		67.96B	70.55B
Curr. liabilities Total current liabilities		13.96B	15.52B
Non-curr. liab. Total non-current liabilities		6.73B	6.63B
Total liabilities		20.69B	22.16B
Total equity		47.27B	48.39B
Total liab. & eq. Total liabilities & equity		67.96B	70.55B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Syngene's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Syngene Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Net Income		4.96B	3.17B
Operating CF Cash flow Operating Activities		11.68B	9.15B
Capex Investments in PPE		-7.60B	-3.44B
Investing CF Cash flow Investing Activities		-7.45B	-8.60B
Dividend Paid		-503.00M	-504.00M
Financing CF Cash flow Financing Activities		-1.42B	-2.15B
Cash (start) Cash at beginning of period		857.00M	3.67B
Cash (end) Cash at end of period		3.67B	2.29B
FCF Free Cash Flow		4.07B	5.71B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Syngene's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2026